APA (7th ed.) Citation

Nwosu, Z. C., Piorońska, W., Battello, N., Zimmer, A. D., Dewidar, B., Han, M., . . . Dooley, S. (2020). Severe metabolic alterations in liver cancer lead to ERK pathway activation and drug resistance. EBioMedicine, 54, . https://doi.org/10.1016/j.ebiom.2020.102699

Chicago Style (17th ed.) Citation

Nwosu, Zeribe C., et al. "Severe Metabolic Alterations in Liver Cancer Lead to ERK Pathway Activation and Drug Resistance." EBioMedicine 54 (2020). https://doi.org/10.1016/j.ebiom.2020.102699.

MLA (9th ed.) Citation

Nwosu, Zeribe C., et al. "Severe Metabolic Alterations in Liver Cancer Lead to ERK Pathway Activation and Drug Resistance." EBioMedicine, vol. 54, 2020, https://doi.org/10.1016/j.ebiom.2020.102699.